12 results · 25ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

PF-400,GF-300,IF-200,PG400,PG400C,AND ED-480

FDA 510(k)
FDA Class 2 ·Ophthalmic

PROFYLE

FDA UDI
Stryker GmbH·04546540363879·Sterilizing Container

NA

FDA UDI
Stryker Leibinger GmbH & Co. KG·34546540244407·BONE SCREWS, CROSS-FIT, SELF-TAPPING

Malibu

FDA UDI
Seaspine Orthopedics Corporation·10889981080594·Modular Poly Driver Sleeve

SENTINELLE BREAST MRI TABLETOP WITH 16 CHANNEL COIL ARRAY FOR SIEMENS 1.5/3T MRI SYSTEMS

FDA 510(k)
FDA Class 2 ·Radiology

RANDOX DIGITOXIN

FDA 510(k)
FDA Class 2 ·Clinical Toxicology

PROTECTOR P21J

FDA Adverse Event
Malfunction ·BECTON DICKINSON, S.A.·Product code ONB·October 1, 2020

VASOVIEW HEMOPRO 2 WITH VASOSHIELD

FDA Adverse Event
Malfunction ·MAQUET CARDIOVASCULAR, LLC·Product code GEI·May 13, 2014

ONETOUCHPING GLUCOSEMGMTSYSTEM

FDA Adverse Event
Malfunction ·ANIMAS CORPORATION·Product code LZG·July 14, 2015

ENDURANT ABDOMINAL STENT GRAFT SYSTEM

FDA Adverse Event
Injury ·MEDTRONIC IRELAND·Product code MIH·January 11, 2013

PM 1250 and PM 2250 ZENEX; PM1282 and PM2282 ZENEX MRI These low voltage (LV) devices are implantable pacemaker pulse generators, intended to be permanently implanted in the body, that have a power supply and electronic circuits that produce a periodic electrical pulse to stimulate the heart. These devices are used as a substitute for the heart's intrinsic pacing system to correct both intermittent and continuous cardiac rhythm disorders.

FDA Enforcement
Class II ·Terminated·St Jude Medical Inc.·October 25, 2017

PM 1260 ASSURITY + These low voltage (LV) devices are implantable pacemaker pulse generators, intended to be permanently implanted in the body, that have a power supply and electronic circuits that produce a periodic electrical pulse to stimulate the heart. These devices are used as a substitute for the heart's intrinsic pacing system to correct both intermittent and continuous cardiac rhythm disorders.

FDA Enforcement
Class II ·Terminated·St Jude Medical Inc.·October 25, 2017